000 01568 a2200445 4500
005 20250515034405.0
264 0 _c20061222
008 200612s 0 0 eng d
022 _a1075-2730
024 7 _a10.1176/ps.2006.57.8.1094
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChakos, Miranda H
245 0 0 _aBaseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
_h[electronic resource]
260 _bPsychiatric services (Washington, D.C.)
_cAug 2006
300 _a1094-101 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCholinergic Antagonists
_xtherapeutic use
650 0 4 _aDatabases as Topic
650 0 4 _aEvidence-Based Medicine
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsychiatry
650 0 4 _aPsychotropic Drugs
_xtherapeutic use
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aGlick, Ira D
700 1 _aMiller, Alexander L
700 1 _aHamner, Mark B
700 1 _aMiller, Del D
700 1 _aPatel, Jayendra K
700 1 _aTapp, Andre
700 1 _aKeefe, Richard S E
700 1 _aRosenheck, Robert A
773 0 _tPsychiatric services (Washington, D.C.)
_gvol. 57
_gno. 8
_gp. 1094-101
856 4 0 _uhttps://doi.org/10.1176/ps.2006.57.8.1094
_zAvailable from publisher's website
999 _c16460182
_d16460182